HCA Healthcare Inc (NYSE: HCA) has a higher price-to-earnings ratio of 15.42x compared to its average ratio, The 36-month beta value for HCA is at 1.70. Analysts have varying views on the stock, with 10 analysts rating it as a “buy,” 6 rating it as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for HCA is 189.60M, and currently, shorts hold a 1.39% of that float. The average trading volume for HCA on May 09, 2024 was 1.03M shares.
HCA) stock’s latest price update
HCA Healthcare Inc (NYSE: HCA)’s stock price has decreased by -1.60 compared to its previous closing price of 314.45. However, the company has seen a -0.01% decrease in its stock price over the last five trading sessions. InvestorPlace reported 2024-05-03 that Blue-chip stocks refer to industry-leading companies with strong financials, dominant market share, global brand recognition and a track record of steady growth over decades. These tend to be extremely stable even during volatile markets, making them appealing long-term holds.
HCA’s Market Performance
HCA Healthcare Inc (HCA) has seen a -0.01% fall in stock performance for the week, with a -5.92% decline in the past month and a 0.70% surge in the past quarter. The volatility ratio for the week is 1.76%, and the volatility levels for the past 30 days are at 2.29% for HCA. The simple moving average for the past 20 days is -1.28% for HCA’s stock, with a 10.66% simple moving average for the past 200 days.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with Barclays repeating the rating for HCA by listing it as a “Overweight.” The predicted price for HCA in the upcoming period, according to Barclays is $356 based on the research report published on March 06, 2024 of the current year 2024.
Bernstein, on the other hand, stated in their research note that they expect to see HCA reach a price target of $301, previously predicting the price at $277. The rating they have provided for HCA stocks is “Mkt Perform” according to the report published on January 04th, 2024.
Goldman gave a rating of “Neutral” to HCA, setting the target price at $271 in the report published on December 11th of the previous year.
HCA Trading at -3.33% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.86% of loss for the given period.
Volatility was left at 2.29%, however, over the last 30 days, the volatility rate increased by 1.76%, as shares sank -5.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.46% lower at present.
During the last 5 trading sessions, HCA fell by -0.01%, which changed the moving average for the period of 200-days by +8.50% in comparison to the 20-day moving average, which settled at $312.53. In addition, HCA Healthcare Inc saw 14.31% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Cuffe Michael S., who sale 1,600 shares at the price of $309.00 back on May 06 ’24. After this action, Cuffe Michael S. now owns 34,124 shares of HCA Healthcare Inc, valued at $494,400 using the latest closing price.
Torres Kathryn A., the SVP-Payer Contracting & Align. of HCA Healthcare Inc, sale 890 shares at $312.00 during a trade that took place back on May 03 ’24, which means that Torres Kathryn A. is holding 21,475 shares at $277,680 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.67 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.08. The total capital return value is set at 0.22.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.04 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at -24.89. The interest coverage ratio of the stock is 4.95.
Currently, EBITDA for the company is 12.73 billion with net debt to EBITDA at 3.16. When we switch over and look at the enterprise to sales, we see a ratio of 1.83. The receivables turnover for the company is 6.64for trailing twelve months and the total asset turnover is 1.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.16.
Conclusion
In conclusion, HCA Healthcare Inc (HCA) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
